Xiros
Private Company
Total funding raised: $10.5M
Overview
Xiros is a long-established, private medical device company specializing in sterile, implantable orthopedic solutions for soft tissue reconstruction. The company leverages a heritage brand (Neoligaments) and a core technology platform centered on high-strength polyester tapes and innovative fixation devices to address a range of sports medicine procedures. With a fully commercialized product portfolio and a direct-to-surgeon commercial strategy, Xiros operates in the revenue-generating stage, targeting improved patient outcomes through durable, evidence-based surgical devices.
Technology Platform
Platform based on high-strength sterile polyester tapes (Poly-Tapes) and mechanical fixation systems (Infinity-Lock Button) for ligament, tendon, and soft tissue reconstruction and repair.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Xiros competes in the crowded sports medicine segment against dominant players like Arthrex, Smith & Nephew, Stryker, and ConMed. Its differentiation lies in its specialized focus on synthetic polyester tape-based solutions and a long heritage in the UK market, positioning it as a niche specialist rather than a full-portfolio provider.